Co-Diagnostics, Inc. Proceeds from Common Stock Issued
Co-Diagnostics, Inc. (CODX) reported Proceeds from Common Stock Issued of $177.87 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-03-14
- Co-Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00.
- Co-Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was -$1.00.
- Co-Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2022-06-30 was $27.87K.
- Co-Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2022-03-31 was $150.00K.
- Co-Diagnostics, Inc. proceeds from issuance of common stock for fiscal 2022 was $177.87K, a 60.51% decline from fiscal 2021.
- Co-Diagnostics, Inc. proceeds from issuance of common stock for fiscal 2021 was $450.40K, a 97.69% decline from fiscal 2020.
- Co-Diagnostics, Inc. proceeds from issuance of common stock for fiscal 2020 was $19.47M, a 254.26% increase from fiscal 2019.
- Co-Diagnostics, Inc. proceeds from issuance of common stock for fiscal 2019 was $5.50M, a 18220.01% increase from fiscal 2018.
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock 0 month as first filed | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$1.00 derived: sum of 2 quarters · filed 2024-03-14 | $27.87K derived: sum of 3 quarters · filed 2024-03-14 | $177.87K 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $27.87K derived: sum of 2 quarters · filed 2023-11-09 | $177.87K 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | $27.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $177.87K 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | $150.00K 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | $450.40K 10-K · filed 2023-03-16 | |||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | $0.00 derived: sum of 3 quarters · filed 2022-03-24 | $19.47M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $19.47M 10-Q · filed 2021-11-12 | $19.47M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $19.47M 10-Q · filed 2021-08-12 | $19.47M derived: sum of 3 quarters · filed 2021-08-12 | $19.47M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $19.47M 10-Q · filed 2021-05-13 | $19.52M 10-Q · filed 2020-05-14 | $19.47M derived: sum of 2 quarters · filed 2021-05-13 | $19.47M derived: sum of 3 quarters · filed 2021-05-13 | $19.47M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-03-02 | $4.23M 10-K · filed 2021-03-25 | $3.88M 10-Q · filed 2020-05-14 | ||||||
| 2020-02-13 | $10.24M 10-K · filed 2021-03-25 | $9.61M 10-Q · filed 2020-05-14 | ||||||
| 2020-01-28 | $5.00M 10-K · filed 2021-03-25 | $4.52M 10-Q · filed 2020-05-14 | ||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $5.50M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $5.50M 10-Q · filed 2020-11-16 | $5.50M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $5.50M 10-Q/A · filed 2020-11-03 | $5.50M derived: sum of 3 quarters · filed 2020-11-03 | |||||
| 2019-03-31 | $5.50M 10-Q · filed 2020-05-14 | $5.50M derived: sum of 2 quarters · filed 2020-05-14 | ||||||
| 2019-02-28 | $5.50M 10-K · filed 2021-03-25 | |||||||
| 2019-02-04 | $5.50M 10-Q/A · filed 2020-11-03 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $30.00K 10-K · filed 2020-03-30 | ||||||
| 2018-09-30 | $30.00K 10-Q · filed 2019-11-12 | |||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $7.07M 10-K · filed 2019-04-01 | ||||||
| 2017-09-30 | $7.07M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |